BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that it will report its fourth quarter and year 2010 financial results on Tuesday, February 8, 2011, after the close of financial markets. Following the announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows:
LIVE access on Tuesday, February 8, 2011
1:30 p.m. Pacific Time (PT) / 4:30 p.m. Eastern Time (ET)
- Telephone (877) 941-8632 (domestic) or (480) 629-9820 (international); conference ID 4404372
- Webcast available at http://www.seattlegenetics.com in the Investors and News section
- Telephone replay will be available beginning at approximately 3:30 p.m. PT on Tuesday, February 8, 2011 through 3:30 p.m. PT on February 10, 2011 by calling (800) 406-7325 (domestic) or (303) 590-3030 (international); conference ID 4404372
- Webcast replay will be available on the Seattle Genetics website at http://www.seattlegenetics.com in the Investors and News section
About Seattle Genetics
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.
Seattle Genetics, Inc.
Peggy Pinkston, 425-527-4160
KEYWORDS: United States North America Washington
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical